191
Participants
Start Date
July 12, 2020
Primary Completion Date
December 28, 2020
Study Completion Date
January 22, 2021
INOpulse
Subjects will be treated by means of an INOpulse device using an INOpulse nasal cannula.
Placebo
Subjects will be treated by means of an INOpulse device using an INOpulse nasal cannula.
Temple University Hospital, Philadelphia
INOVA, Falls Church
St. Francis Medical Center, Richmond
Memorial Regional Medical Center, Richmond
Chippenham Medical Center, Richmond
Pulmonary Associates of Richmond, Richmond
St. Mary's Hospital, Richmond
Johnston-Willis Hospital, Richmond
University of Miami Health System, Miami
The Ohio State University Wexner Medical Center, Columbus
Mercy Health St. Vincent Medical Center, Toledo
The Lung Research Center (St. Luke's), Chesterfield
Houston Methodist, Houston
Banner University Medical Center, Phoenix
University of New Mexico Hospital, Albuquerque
Kaiser Permanente - Zion Medical Center, San Diego
Kaiser Permanente - San Diego Medical Center, San Diego
Lead Sponsor
Bellerophon Pulse Technologies
INDUSTRY